AU4426289A - Methods for interfering with hiv multiplication and composition for the treatment of aids - Google Patents
Methods for interfering with hiv multiplication and composition for the treatment of aidsInfo
- Publication number
- AU4426289A AU4426289A AU44262/89A AU4426289A AU4426289A AU 4426289 A AU4426289 A AU 4426289A AU 44262/89 A AU44262/89 A AU 44262/89A AU 4426289 A AU4426289 A AU 4426289A AU 4426289 A AU4426289 A AU 4426289A
- Authority
- AU
- Australia
- Prior art keywords
- interfering
- aids
- treatment
- composition
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25368688A | 1988-10-05 | 1988-10-05 | |
US253686 | 1988-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4426289A true AU4426289A (en) | 1990-05-01 |
Family
ID=22961299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44262/89A Abandoned AU4426289A (en) | 1988-10-05 | 1989-09-27 | Methods for interfering with hiv multiplication and composition for the treatment of aids |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4426289A (en) |
WO (1) | WO1990003791A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU617850B2 (en) * | 1988-08-24 | 1991-12-05 | Akzo N.V. | Heparin fragments and fractions with anti-hiv action |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69232615T2 (en) * | 1991-05-02 | 2003-01-30 | Cohen, Irun R. | COMPOSITIONS FOR PREVENTING AND / OR TREATING PATHOLOGICAL PROCESSES |
IT1248060B (en) * | 1991-06-14 | 1995-01-05 | Italfarmaco Spa | ACILATED HEPARINS AS INHIBITORS OF RETROVIRUS REPLICATION |
US5861382A (en) * | 1992-05-01 | 1999-01-19 | Yeda Research And Development Co. Ltd. | Methods for regulation of active TNF-α |
US6750207B1 (en) | 1992-05-01 | 2004-06-15 | Yeda Research And Development Co. Ltd. | Compositions for the regulation of cytokine activity |
AU4325499A (en) | 1998-06-01 | 1999-12-20 | University Of Maryland Biotechnology Institute | Receptor ligand antagonist complexes and their use in treating or preventing receptor mediated diseases |
US7285536B2 (en) | 2001-12-05 | 2007-10-23 | Yeda Research And Development Co., Ltd. | Anti-cancer therapeutic compounds |
AU2003225724A1 (en) | 2002-03-11 | 2003-09-29 | Momenta Pharmaceuticals, Inc. | Analysis of sulfated polysaccharides |
US7968082B1 (en) | 2007-01-26 | 2011-06-28 | Momenta Pharmaceuticals, Inc. | Evaluating mixtures of low molecular weight heparins by NMR |
US7790466B1 (en) | 2007-01-26 | 2010-09-07 | Momenta Pharmaceuticals, Inc. | Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping |
US9139876B1 (en) | 2007-05-03 | 2015-09-22 | Momenta Pharmacueticals, Inc. | Method of analyzing a preparation of a low molecular weight heparin |
US8435795B2 (en) | 2010-01-19 | 2013-05-07 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
CN101942039B (en) * | 2010-09-16 | 2012-11-28 | 山东海科化工集团有限公司 | Parnaparin production method |
WO2012115952A1 (en) | 2011-02-21 | 2012-08-30 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1214609B (en) * | 1985-05-17 | 1990-01-18 | Opocrin Spa | HEXOSAMINOGLICANS DEPOLYMERIZED SULPHATES FOR ANTI-THROMBOTIC, FIBRINOLITHIC, ANTI-INFLAMMATORY ACTIVITIES, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
-
1989
- 1989-09-27 AU AU44262/89A patent/AU4426289A/en not_active Abandoned
- 1989-09-27 WO PCT/US1989/004249 patent/WO1990003791A1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU617850B2 (en) * | 1988-08-24 | 1991-12-05 | Akzo N.V. | Heparin fragments and fractions with anti-hiv action |
Also Published As
Publication number | Publication date |
---|---|
WO1990003791A1 (en) | 1990-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4636589A (en) | Tissue culture antiviral processes and compositions | |
AU1676588A (en) | Treatment of materials | |
AU4205789A (en) | Method and composition for the treatment and prevention of viral infections | |
AU4019289A (en) | Hiv protease inhibitors useful for the treatment of aids | |
AU589438B2 (en) | Transplantable artificial tissue and process | |
AU1608188A (en) | Improved superabsorbent composition and process | |
AU3072989A (en) | Skin treatment composition | |
AU1520188A (en) | Compositions and methods of treatment of timber | |
AU2755788A (en) | Chelating compounds and their use | |
AU4426289A (en) | Methods for interfering with hiv multiplication and composition for the treatment of aids | |
AU1114388A (en) | Anesthetic composition and method of using the same | |
AU570601B2 (en) | Puriifying blood and plasma | |
AU5262979A (en) | Use of argon in the basic oxygen process | |
AU3604289A (en) | Treatment of arthritis | |
AU5266186A (en) | Hard tissue prosthetics and process for the preparation thereof | |
AU1279788A (en) | Compounds and treatment | |
AU6660090A (en) | Treatment of depression | |
AU3974989A (en) | Sequence-specific amplification techniques | |
AU3836489A (en) | Treatment of immunodeficiency | |
AU3553489A (en) | Novel compounds and treatment | |
AU576717B2 (en) | N6 - bicycloadenosines and methods of use | |
AU7125091A (en) | Metal treatment | |
AU4812393A (en) | Use of rapamycin in the treatment of aids | |
AU4319393A (en) | Use of indolocarbazols in aids treatment | |
AU3989589A (en) | Improved biosensor and the method of its use |